Discover how early optimization in stable cell line development accelerates timelines and reduces downstream bottlenecks.

Demand for biopharmaceuticals, regenerative medicine and cancer research is expanding opportunities in drug discovery, vaccines, personalized medicine and advanced cell-based technologies.Dublin, Sept ...

OPM Biosciences, a cell culture media and bioprocess solutions company, today announced two new offerings that extend its OPM-CHO™ platform into biosimilar development and manufacturing: the ...

WUHAN, HUBEI PROVINCE, CHINA, February 15, 2026 /EINPresswire.com/ — In the complex landscape of life science research, selecting the right cellular model is a ...

Meibomian gland carcinoma is one of the rarest and most treacherous malignancies in ocular oncology, and for decades it has ...

Human induced pluripotent stem cells (hiPSCs) are considered a promising tool in medicine, with the potential to unlock treatments for many health conditions such as neurodegenerative diseases and ...

How visual-based assessment assists researchers to judge cellular identity and avoid experimental bias HUSTON, TX, ...

A team of scientists has led one of the first studies to reap the benefits of a first-of-its-kind industry reference cell. The research, led by the University of Maryland and the U.S. National ...

Advances in media optimization, cell engineering, and AI are reshaping intensified bioprocessing for higher productivity, better quality, and greater manufacturing efficiency.